A Novel SLC25A1 Inhibitor, Parthenolide, Suppresses the Growth and Stemness of Liver Cancer Stem Cells with Metabolic Vulnerability

Scientists showed that administration of parthenolide stimulated cell cycle arrest at the G1 phase, induced apoptosis, and decreased the stemness of liver cancer stem cells.